Histological characterization of the focal cortical Pten LOF model.
A) Experimental timeline showing induction of hSyn-Cre-GFP or Control hSyn-GFP AAV at P0 and EEG recording in adulthood. The location of cortical Cre expression relative to Bregma did not differ between groups. B) Representative images of GFP expression in a Control mouse brain, demonstrating expression predominantly in one hemisphere of the cortex. Projections from affected neurons can be seen in white matter tracts including the fornix, internal capsule, corpus callosum, and cerebral peduncle. C1) Quantification of lesion severity and neuron density in Cre-expressing animals. There were fewer Cre-expressing neurons per unit area in the Pten LOF and Pten-Ric LOF groups, which was at least partially attributable to a decrease in cell density in these groups. No significant differences in Cre expression remained when Cre expression was calculated based on cell density rather than area. C2) Representative images of DAPI and Cre fluorescence in the cortex of Pten LOF and Pten-Rap LOF animals. Cell density and Cre density in Pten-Rap LOF animals was indistinguishable from Controls. D1) Phospho-S6, a marker of mTORC1 activity, was increased by Pten LOF and reduced to control levels by concurrent Rptor loss. Phospho-S6 was also increased from Control levels in Pten-Ric LOF, indicating that mTORC1 hyperactivity was not normalized by Rictor loss. Combined Rptor/Rictor loss also normalized phospho-S6 expression. D2) phospho-Akt, a marker of mTORC2 activity, was increased in Pten LOF and normalized by Rictor loss, but not by Rptor. Combined Rptor/Rictor loss also normalized phospho-Akt expression. Error bars show mean ± s.e.m. ns indicates p>0.05, * indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001, and **** indicates p<0.0001 as assessed by statistical tests indicated in Table 3. Diagram created with BioRender.com.
© 2024, BioRender Inc. Any parts of this image created with BioRender are not made available under the same license as the Reviewed Preprint, and are © 2024, BioRender Inc.